targeted-toxins

Blanco-Centurion CA, Salin-Pascual R, Gerashchenko D, Greco MA, Lappi DA, Kilduff TS, Shiromani PJ (2000) DBH-saporin lesions the locus coeruleus, but does not produce cataplexy or abnormal REM sleep triggering. Neuroscience 2000 Abstracts 566.17. Society for Neuroscience, New Orleans, LA.

Summary: Recently, canine narcolepsy was associated with a mutation in the hypocretin-2 receptor (Lin et al., 1999), which binds the neuropeptide hypocretin, also known as orexin. The locus coeruleus receives a very heavy projection of HCRT/OX fibers, and the LC also contains HCRT/OX receptor mRNA. Silence of LC neurons is hypothesized to be key in triggering cataplexy and REM sleep. To test this hypothesis, DBH-saporin was used to selectively lesion the LC. Male Sprague-Dawley rats (400-450 g) instrumented for recording sleep were given DBH-saporin (n=4) (500ng/0.5ul) via a micropipette to the LC. Control rats were administered 192-saporin (n=3), or saline (n=4). Two days later, sleep recordings were obtained for 7 consecutive days. The rat’s behavior was videotaped at night. To identify whether cataplexy was induced, the alpha antagonist, Prazosin was administered (1500h, 500mg/kg, IP) and then sleep and video recordings were made for three hours. Brains were removed for histology. DBH-saporin completely lesioned the LC neurons. However, there were no changes in wakefulness, nonREM or REM sleep. Video recordings also did not reveal any cataplexy episodes. The application of Prazosin did not induce cataplexy or diminish muscle tone in DBH-saporin LC treated rats. Historically, LC lesions have never been found to induce cataplexy. Use of DBH-saporin provides a more specific lesion restricted to the LC neurons where the HCRT/OX receptor mRNA is localized. Our findings indicate that LC neurons are not essential for maintaining muscle tone or wakefulness.

Related Products: Anti-DBH-SAP (Cat. #IT-03)

Schreihofer AM, Stornetta RL, Guyenet PG (2000) Regulation of sympathetic vasomotor tone and arterial pressure by the rostral ventrolateral medulla after elimination of C1 neurons in rat. Neuroscience 2000 Abstracts 310.7. Society for Neuroscience, New Orleans, LA.

Summary: The rostral ventrolateral medulla (RVLM) tonically stimulates sympathetic preganglionic neurons to maintain arterial pressure (AP). Although the C1 neurons in the RVLM may have a sympathoexcitatory function, it is not known whether they are the essential presympathetic RVLM neurons. In the present study, we selectively destroyed spinally projecting C1 cells (∼84%) with bilateral microinjections (spinal segments T2-T3) of an anti-dopamine-betahydroxylase antibody conjugated to saporin (anti-DβH-SAP). 3-5 weeks later these rats had a normal AP and splanchnic nerve activity (SNA) under chloralose anesthesia. Extracellular recording and juxtacellular labeling of bulbospinal barosensitive neurons in RVLM revealed that after anti-DβH-SAP only the lightly myelinated RVLM neurons with no or very low levels of tyrosine hydroxylase immunoreactivity were preserved. In these rats, inhibition of RVLM (muscimol 100 pmol/100 nl/side) eliminated SNA and decreased AP as seen in control rats. However, treatment with anti-DβHSAP reduced the sympathoexcitatory and pressor responses to electrical stimulation in RVLM. Although treatment with anti-DβH-SAP also eliminated A5 noradrenergic cells, rats with selective lesions of A5 cells (local microinjection of 6-hydroxydopamine) displayed no deficits to stimulation of the RVLM. These data suggest basal sympathetic vasomotor tone relies primarily on non-catecholaminergic presympathetic cells in the RVLM. In contrast, bulbospinal adrenergic neurons are important for the increased SNA and AP produced by stimulation of the RVLM.

Related Products: Anti-DBH-SAP (Cat. #IT-03)

Ciriello J, Rosas-Arellano MP, Solano-Flores LP (2000) Intrathecal injections of saporin conjugated substance-P alter the development of renal hypertension. Neuroscience 2000 Abstracts 310.2. Society for Neuroscience, New Orleans, LA.

Summary: We have recently shown that there is an up-regulation of mRNA encoding Substance-P (SP) in dorsal root ganglia in the two kidney, one clip (2K1C) model of renal hypertension. In this study, the effect of intrathecal injections of the toxin saporin conjugated to SP (SAP; 5 x 10-6 M) on the development of 2K1C hypertension was investigated in male Wistar rats. Rats were randomly assigned to 2 groups and instrumented with an intrathecal cannula that ended at the T10-T12 spinal level. Arterial pressure (AP) and heart rate (HR) were recorded using the indirect tail-cuff method. After a 1 week control period, one group of animals received a single 10 µl injection of SAP and the other an equal volume of the saline vehicle (control). Two weeks later a clip was placed on the left renal artery in all animals. Injections of either SAP or the vehicle did not alter AP and HR compared to pre-injection levels. In addition, AP and HR were not altered in the SAP group compared to controls for the 2 week period prior to the renal clip. However, during the 4 weeks after the renal clip, AP and HR in the SAP group were significantly lower compared to the control animals. These data suggest that dorsal horn neurons containing SP receptors and that receive afferent renal nerve inputs are involved in renal hypertension.

Related Products: SP-SAP (Cat. #IT-07)

Vulchanova L, Olson TH, Elde R, Honda CN (2000) Role of IB4-binding sensory neurons in the effects of intradermal capsaicin injection. Neuroscience 2000 Abstracts 212.7. Society for Neuroscience, New Orleans, LA.

Summary: We have shown previously that a unilateral injection of a conjugate of the lectin IB4 and the toxin saporin (IB4-SAP) into sciatic nerve of rats results in loss of IB4-binding neurons and transient increase in thermal and mechanical nociceptive thresholds. The thresholds were maximally increased 10 days post-treatment and returned to baseline levels by day 21. In the present study, we examined the responses of IB4-SAP treated rats after intradermal injection of capsaicin, which results in acute nocifensive behavior followed by thermal and mechanical hyperalgesia. The nocifensive behavior of IB4-SAP treated rats 10, 21 and 42 days post-treatment was 6%, 36% and 47%, respectively, of the behavior of control treated rats. IB4-SAP treated rats injected with capsaicin did not develop thermal or mechanical hyperalgesia at any of the time points examined. These results suggest that the increase in thermal nociceptive thresholds after IB4-SAP treatment is due to loss of VR1-expressing IB4-binding neurons since the nocifensive behavior is most likely mediated by the capsaicin receptor VR1, which also transduces noxious thermal stimuli. In addition, VR1 in surviving neurons may contribute to the recovery of thermal nociceptive thresholds. Finally, our results suggest that IB4-binding neurons are required for development of capsaicin-mediated hyperalgesia, and that the recovery of the responsiveness of IB4-SAP treated rats to noxious stimuli under normal conditions is not accompanied by recovery of the mechanisms underlying hyperalgesia.

Related Products: IB4-SAP (Cat. #IT-10)

Martin JL, Sloviter RS (2000) Focal hippocampal hyperexcitability after focal interneuron ablation in the rat by substance P-saporin. Neuroscience 2000 Abstracts 389.13. Society for Neuroscience, New Orleans, LA.

Summary: Hyperexcitability after prolonged seizures or head trauma may result from interneuron malfunction or loss; but a causal relationship is in doubt because global insults produce widespread brain damage and other effects. We have therefore sought to destroy interneurons selectively using stable Substance P-saporin (SSPsap; ATS); a neurotoxin internalized by SP receptor (SPR)-expressing neurons. Improved immunofluorescent methods revealed that most GABA-; parvalbumin (PV)-; and somatostatin (SS)-positive (+) cells of all hippocampal regions (dentate gyrus and areas CA1-CA3) are SPR+; but that granule cells; mossy cells; and CA1-3 pyramidal cells are not. Intrahippocampal injections of SSPsap or vehicle were made under urethane anesthesia in 3 sites (20nl/site) of the dorsal hippocampus of 6 male Sprague-Dawley rats/group. After 5-90 days; rats were blindly evaluated in two sites for CA1 pyramidal cell and dentate granule cell responses to perforant path stimulation (PPS). SSPsap-treated rats exhibited relatively normal responses in some sites; but pathophysiology at other sites that was virtually identical to that seen after prolonged PPS or kainate (multiple population spikes and paired-pulse disinhibition in response to 0.1-2.0Hz perforant path (PP) stimuli). Abnormal responses were observed at the earliest time tested (5 days); and at 90 days. Anatomical analysis revealed selective loss of SPR+; PV+; SS+; and GABA+ neurons; and survival of principal cells and extrinsic afferents. Importantly; “epileptic” pathophysiology was observed exclusively in areas of interneuron loss. These data indicate that the pathophysiology produced by status epilepticus or head trauma can be replicated focally by selective interneuron loss alone; and provide the first direct evidence that highly focal interneuron loss per se is capable of replicating “epileptic” disinhibition and hyperexcitability. In addition; the pathophysiology is restricted to the region of the affected interneuron somata; suggesting a highly localized influence of inhibitory interneurons. Supported by: NIH grant NS18201.

Related Products: SSP-SAP (Cat. #IT-11)

ATS Poster of the Year Winner. Read the featured article in Targeting Trends.

Petruska JC, Johnson RD (2000) Differential input to a nociceptive specific reflex by trka-positive and trka-negative small diameter DRG afferents. Neuroscience 2000 Abstracts 354.7. Society for Neuroscience, New Orleans, LA.

Summary: The cutaneus trunci muscle (CTM) reflex is a nociceptive specific reflex in the rat. We examined whether particular subtypes of afferents may be differentially involved in the reflex. In particular, we wanted to determine if there were differences in input to the reflex between those expressing trkA receptors, and those lacking trkA receptors. We approached this question with two techniques. The selective neurotoxin 192-saporin was injected into the left T13 DRG to destroy the p75 receptor-bearing neurons. Two to three weeks following injection, the ability of the injected DRG to elicit the CTM reflex was examined in contrast to uninjected DRG. The ganglia were also retrieved for histochemical examination. In all cases where histochemical examination revealed a clear depletion of the neurotrophin-bearing neurons the injected DRG lacked the ability to induce the CTM reflex. Histochemical markers for the trkA-negative small diameter afferents appeared normal in all cases. The second approach utilized the trans-synaptic neuronal tracer pseudorabies virus (PRV). PRV was injected into the CTM to generate a retrograde tracing of the reflex circuit, including the afferents involved. This resulted in specific labelling of many small diameter DRG neurons, the vast majority of which expressed trkA. The CTM reflex may therefore not be a suitable monitor for inputs from the trkA-negative small diameter afferents, especially as regards its use in collateral sprouting experiments. These data indicate that inputs from the two populations of afferents are likely processed differently.

Related Products: 192-IgG-SAP (Cat. #IT-01)

Vogt LJ, Sim-Selley LJ, Childers SR, Wiley RG, Vogt BA (2000) Distribution of mu-opioid receptors and activated G-proteins in rat cingulate cortex and alterations following removal of noradrenergic afferents. Neuroscience 2000 Abstracts 238.1. Society for Neuroscience, New Orleans, LA.

Summary: Anterior cingulate cortex (ACC) is involved in acute and chronic pain processing. Here we define opioid architecture throughout rat cingulate cortex, relate mu-opioid receptor and G-protein stimulated binding in particular layers, and localize binding to noradrenergic terminals with immunotoxin lesions (anti-DBH-saporin). [3H]DAMGO binding was highest in areas 32 and 24 with a peak in layer I. Midcingulate area 24′ and posterior area 29 had lower and homogeneous binding. DAMGO stimulated [35S]GTPγS binding in area 24′ was similar to that in areas 32 and 24, while area 29 had very low and homogeneous binding. Undercut lesions reduced [3H]DAMGO binding in all layers with greatest loss in layer I, while DAMGO-stimulated [35S]GTPγS binding losses occurred only in layers I-III. Since neurons in the midline thalamic nuclei and locus coeruleus synthesize mu-opioid receptors, noradrenergic afferents were removed with anti-DBH-saporin. This toxin reduced [3H]DAMGO binding only in layer I of areas 32 and 24, while DAMGO-stimulated [35S]GTPγS binding increased in layer II of areas 32 and 24, had no changes in area 24′, and decreased binding in layer I of area 29. Thus, in addition to their actions on ACC neurons, other sites of opiate drug actions are through mu-opioid heteroreceptors on glutamatergic thalamic and noradrenergic locus coeruleus afferents to ACC.

Related Products: Anti-DBH-SAP (Cat. #IT-03)

Burgess SE, Vanderah TW, Mantyh PW, Malan Jr TP, Ossipov MH, Lappi D, Lai J, Porreca F (2000) Dermorphin-saporin targets tonic descending facilitation in the rostral ventromedial medulla to block and reverse neuropathic pain. Neuroscience 2000 Abstracts 243.6. Society for Neuroscience, New Orleans, LA.

Summary: The hypothesis that chronic pain from L5/L6 spinal nerve ligation (SNL) is due to tonic activation of descending pain facilitation mechanisms was explored by selective targeting mu (μ) opioid receptor expressing cells in the RVM (i.e., presumably, ON cells). Rats were treated with a single RVM injection of dermorphin (DERM)(μ agonist), saporin (SAP), or dermorphin-saporin conjugate (DERM-SAP) and responses to non-noxious (von Frey filaments) or noxious (Hargreave’s test) stimuli characterized. DERM-SAP retained high affinity for μ receptors and acutely produced antinociception (tail-flick test), indicating agonist actions of the conjugate. Decreased staining of μ receptor-expressing cells was seen in superficial dorsal horn and in dorsal root ganglia 28 days after intrathecal injection of DERM-SAP, but not DERM or SAP. RVM DERM-SAP, DERM or SAP did not significantly alter baseline thresholds to von Frey filaments or noxious heat applied to the paw over 28 days. At day 28, RVM pretreated rats were subjected to sham- or SNL surgery and responses to tactile and heat stimuli monitored 7 days later (i.e., 35 days after the RVM pretreatment). DERM and SAP pretreated SNL rats showed the expected development of tactile allodynia and thermal hyperalgesia, while DERM-SAP pretreated rats did not. The RVM pretreatments did not alter responses in sham-operated controls. Administration of RVM DERM-SAP, but not SAP or DERM, to SNL rats showed full reversal of established allodynia/hyperalgesia by day 14. RVM pretreatment with β-funaltrexamine (β-FNA; opioid μ antagonist) prevented the antiallodynic and antihyperalgesic effects of subsequent DERM-SAP injection. These data, together with findings of blockade of SNL pain with RVM lidocaine or lesions of the dorsolateral funiculus, support the possibility of tonic activation of descending facilitation as a basis for chronic neuropathic pain.

Related Products: Dermorphin-SAP / MOR-SAP (Cat. #IT-12)

Han JS, Bizon JL, Chun HJ, Maus CE, Gallagher M (2000) Feedback HPA axis to stress is impaired in rats with selective removal of hippocampal cholinergic input. Neuroscience 2000 Abstracts 388.16. Society for Neuroscience, New Orleans, LA.

Summary: Activation of intracellular glucocorticoid receptors (GRs) may play a permissive role in mechanisms that lead to degeneration of hippocampal neurons in pathological conditions such as Alzheimer’s disease (AD). A previous study demonstrated that loss of cholinergic input from cells in the basal forebrain, a prominent feature of AD, reduced glucocorticoid receptor mRNA expression in the hippocampus in rats (Bizon et al., 1999). This experiment was conducted to see if reduced GRs after loss of cholinergic input would impair the function of the HPA axis in response to acute restraint stress. The cholinergic lesion was made by microinjections of the immunotoxin 192-IgG-saporin into the medial septal area and the vertical limb of the diagonal band. About 2 weeks later, rats were prepared with intravenous silastic catheters in the right jugular vein. After 5 days recovery, restraint stress for 1 hr was performed at 9:00 (a.m.). Blood (∼|50ul) was sampled repeatedly via the jugular catheter immediately (0 min) and at various times following the termination of the stressor (1 hr, 2 hr, 4 hr). For each group, negative feedback after a peak response to restraint was evident as a general trend of decreasing corticosterone that approached basal values by four hours after the cessation of stress. However, the speed of recovery to baseline differed between groups. Rats with loss of cholinergic input had higher corticosterone concentrations for a longer period after restraint stress than control rats, reflecting a diminished negative feedback function. These results suggest a mechanism whereby loss of basal forebrain cholinergic neurons in AD could contribute to a dysregulation of the HPA axis and more protracted exposure to high amounts of glucocorticoids. As an extension of the glucocorticoid cascade hypothesis, glucocorticoids might then be a factor in endangering hippocampal neurons in this disease.

Related Products: 192-IgG-SAP (Cat. #IT-01)

Jasmin L, Arsenault P, Ohara PT, Marchand S (2000) Chronic noradrenergic spinal denervation in rats does not produce long-term hyperalgesia. Neuroscience 2000 Abstracts 243.7. Society for Neuroscience, New Orleans, LA.

Summary: Pharmacological studies have established that noradrenaline tonically inhibits spinal nociceptive transmission. We tested the hypothesis that chronically decreasing spinal noradrenaline would result in a disinhibition of nociceptive afferents resulting in behavioral hyperalgesia. We destroyed noradrenergic cells innervating the spinal cord using dopamine beta-hydroxylase antibodies linked to the neurotoxin saporin (anti-DBH-Sap). Male rats (n=6) were injected intrathecally with 4µg/10µl of anti-DBH-Sap, and their responses to nociceptive and non-nociceptive stimuli was monitored over a period of 65 days. Compared to controls (n=6), a significant (p< 0.05) decrease to hot plate (46oC) nociceptive responses could be observed during the first week post-treatment, but no differences were found at later times. At no point was there any altered response to innocuous stimuli. When tested for response to cold water stress, both treated and control animals showed analgesia, demonstrating that descending pain inhibition could still be activated. At 65 days, a formalin test showed no difference between treated (1.1 +/-0.5) and control (0.8 +/-0.5) groups. Post-mortem immunostaining of spinal cords for DBH, however, confirmed that noradrenergic denervation of the spinal cord had occurred in treated animals. These results suggest that a reorganization of the spinal cord following noradrenergic denervation is sufficient to reestablish normal nociceptive responses.

Related Products: Anti-DBH-SAP (Cat. #IT-03)